DNA damage induces down-regulation of PEPCK and G6P gene expression through degradation of PGC-1α

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 8, 2011, Pages 589-594

  Kim, Hyun Ju ^a   Jee, Hye Jin ^a   Yun, Jeanho ^a  

^a Dong A University   (South Korea)

Author keywords

DNA damage response; G6P; gluconeogenesis; PEPCK; PGC 1 ; transcription regulation

Indexed keywords

GLUCOSE 6 PHOSPHATASE; HEAT SHOCK PROTEIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PPARGC1A PROTEIN, HUMAN; PRIMER DNA; TRANSCRIPTION FACTOR;

ARTICLE; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYDROLYSIS; METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA DAMAGE; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE-6-PHOSPHATASE; HEAT-SHOCK PROTEINS; HUMANS; HYDROLYSIS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; ULTRAVIOLET RAYS;

EID: 79961051184     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr053     Document Type: Article

References (24)

1. Zhou BB and Elledge SJ. The DNA damage response: Putting checkpoints in perspective. Nature 2000, 408: 433-439.
2. Bartek J and Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001, 13: 738-747. (Pubitemid 33042735)
3. Maki CG, Huibregtse JM and Howley PM. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 1996, 56: 2649-2654. (Pubitemid 26170702)
4. Hofmann F, Martelli F, Livingston DM and Wang Z. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev 1996, 10: 2949-2959. (Pubitemid 26412522)
5. Palombella VJ, Rando OJ, Goldberg AL and Maniatis T. The ubiquitinproteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994, 78: 773-785. (Pubitemid 24294453)
6. Hanson RW and Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 1997, 66: 581-611. (Pubitemid 27274668)
7. Roesler WJ. What is a cAMP response unit? Mol Cell Endocrinol 2000, 162: 1-7.
8. Hall RK, Sladek FM and Granner DK. The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Proc Natl Acad Sci U S A 1995, 92: 412-416.
9. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F and Kitamura Y, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423: 550-555. (Pubitemid 36648580)
10. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R and Granner DK. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 2000, 275: 30169-30175.
11. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J and Adelmant G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413: 131-138. (Pubitemid 32867868)
12. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A and Rudolph D, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413: 179-183. (Pubitemid 32867880)
13. Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J and Fukamizu A. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem 2004, 279: 23158-23165. (Pubitemid 38685621)
14. Kim MA, Kim HJ, Brown AL, Lee MY, Bae YS, Park JI and Kwak JY, et al. Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif. Exp Mol Med 2007, 39: 205-212. (Pubitemid 46683406)
15. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999, 59: 4375-4382. (Pubitemid 29418757)
16. Hershko A and Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998, 67: 425-479. (Pubitemid 28411135)
17. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001, 70: 503-533. (Pubitemid 32663902)
18. Warburg O. On the origin of cancer cells. Science 1956, 123: 309-314.
19. Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM and Ong CN, et al. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: Mechanism of tumorigenesis. Mol Cell Proteomics 2006, 5: 1119-1130. (Pubitemid 43985935)
20. Sutherland C, O'Brien RM and Granner DK. New connections in the regulation of PEPCK gene expression by insulin. Philos Trans R Soc Lond B Biol Sci 1996, 351: 191-199. (Pubitemid 126745329)
21. Mandal S and Davie JR. An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells. BMC Cancer 2007, 7: 181.
22. Feilchenfeldt J, Brundler MA, Soravia C, Totsch M and Meier CA. Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: Reduced expression of PPARgamma-coactivator 1 (PGC-1). Cancer Lett 2004, 203: 25-33. (Pubitemid 37506080)
23. Watkins G, Douglas-Jones A, Mansel RE and Jiang WG. The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer. Oncol Rep 2004, 12: 483-488.
24. Jiang WG, Douglas-Jones A and Mansel RE. Expression of peroxisomeproliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer 2003, 106: 752-757. (Pubitemid 36993400)